This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Breastfeeding (breast engorgement)

Authoring team

In breast engorgement there is both milk and tissue fluid overfilling the breast (1).

It is caused by

  • venous and lymphatic stasis - before the onset of milk secretion (2)
  • obstruction of the lactiferous ducts - approximately 48 - 96 hours after birth, the mother's breast fills with milk and inadequate emptying of milk leads to over distension of the alveolar space (2,3).

Engorgement of the breast is usually seen within a week after birth (can be later too). It can be divided into

  • primary engorgement - seen during the first few days after the infant is born where the mother's body is trying to adjust to the demand for breast milk from the baby
  • secondary engorgement - occurs later where there is less frequent/restricted feeding or decreased demand from the baby

Typical clinical features include:

  • the breast is hard tender and/or painful (2)
  • the skin becomes shiny and diffusely red
  • usually both breasts are affected
  • nipples may be stretched tight and flat
  • there is difficulty for the baby to attach and remove milk
  • milk does not flow easily
  • a fever which subsides within 24 hours is usually present (1)

Augmentation mamoplasty has been identified as a cause since breast engorgement is seen more commonly in mothers who have had such operations (3).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.